{"id":449256,"title":"Notice of Intent Published in Canada Gazette Parts I and II, December 7, 2002 and Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T18:40:34.241000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/notice-intent-published-canada-gazette-parts-december-7-2002-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-topic.html?wbdisable=false","snippet":"Notice of Intent Published in Canada Gazette Parts I and II, December 7, 2002 and Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A Contact Name: Policy and Strategic Planning Division Tel: (613) 954-6785 Fax: (613) 952-9805 E-Mail:…","rawSnapshotUrl":"/api/snapshots/raw/449256","browseUrl":"https://replay.healtharchive.ca/job-6/20260103184034/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/notice-intent-published-canada-gazette-parts-december-7-2002-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-topic.html?wbdisable=false#ha_snapshot=449256","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}